BioStock: Saniona receives heightened interest in Q2

During 2022, Danish biotech Saniona has initiated restructuring measures that are expected to reduce future operating expenses by up to 75 per cent. Meanwhile, the company has seen a sharp increase in interest from over 50 companies that now have carried out evaluations on one or more of Saniona’s preclinical or clinical pipeline programmes.

Read the article about Saniona at biostock.se:

https://www.biostock.se/en/2022/08/saniona-receives-heightened-interest-in-q2/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/